Key Market Indicators
The Czech Diagnostic Reagent market is projected to hit €34.7 million by 2028, growing from €30.2 million in 2023. This represents an annual compound growth rate (CAGR) of 2.2%. Since 2013, the Czech market has seen a steady increase of 4.1% annually. Spain, the United Kingdom, and Finland follow closely in the rankings, securing the second, third, and fourth spots respectively. On the export front, Czech Diagnostic Reagent exports are expected to reach $105 million by 2028, up from $88.7 million in 2023. This marks an annual growth rate of 2.7%. Since 1998, Czech exports have risen by 3.8% each year. In 2023, the Czech Republic ranked 23rd globally, with the United Arab Emirates surpassing it with $88.7 million in exports. Germany, the Netherlands, and the United Kingdom were ranked second, third, and fourth, respectively. Czech Diagnostic Reagent imports are forecasted to climb to $241 million by 2028, increasing from $211.9 million in 2023. This reflects an average annual growth rate of 2%. Since 1998, the country's demand for diagnostic reagents has grown by 2.6% each year.
